Navigation Links
Royal Brompton Hospital Finds A New Technique To Detect Child Heart Killer

A new technique developed by cardiologists of Royal Brompton Hospital helps in determining the risk of sudden death due to weakness in heart of young people. The// process involves injecting a dye called gadolinium into the patient's vein and then scanning for the results using MRI (Magnetic Resonance Imaging).

The scan indicates heart scar tissue that can clue-in doctors to dilated cardiomyopathy or DCM, which otherwise will go undetected. With DCM, the heart is either weak or enlarged, resulting in the difficulties for pumping blood. It is a common form of heart muscle disease with children. The gadolinium tends to linger around the scar tissue due to a lower blood supply in scar tissue than other normal tissues. The gadolinium's special magnetic property also indicates scar tissue brightly on the scan thus making it very easy to detect.

Lead researcher Professor Dudley Pennell said: “the scans should aid in choosing treatment choices. Prior to this technique it was difficult to decide which patients could be treated effectively using drugs alone, and which patients needed life-saving devices implanted.” Professor Peter Weissberg, medical director of the British Heart Foundation, said that this was an important advance that will help doctors prevent lives being lost to the condition.
SR
'"/>




Page: 1

Related medicine news :

1. A Royal Flush And A White Elephant
2. Nursing A Threat : NHS Nurses May Stage A Royal Protest
3. Sandwich Royale, Adorns Shelves of Selfridges in London
4. Royal Highland Show Cancelled Over Bird Flu Fears
5. Muhammad Ali In Battle Royale With Obesity
6. Royal College Issues Revised Guidelines for Face Transplantation
7. Oracle Corp. to help build worlds first "Digital Hospital"
8. Apollo Hospitals to consider listing on US Bourses in 2003
9. The World Bank funds private Hospital in India
10. Link Between Hyperglycemia & Hospital Mortality
11. Reducing The Rate Of Hospital Acquired Infections
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... June 23, 2017 , ... Ulster University, Magee Campus ... from 9 am to 3 pm to present to graduate students exciting new and ... an original curriculum project led by The Health Improvement Service of the Western Health ...
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, ... families and business owners in North Central West Virginia, is embarking on a ... differently abled residents in the region. , The Stepping Stones organization offers a ...
(Date:6/22/2017)... Indianapolis, IN (PRWEB) , ... June 22, 2017 ... ... employee benefits advisory organization, is pleased to welcome Whipple & Company as its ... on the clear purpose of balancing their clients’ risk while tailoring optimized benefit ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... awards for environmental excellence. Maryland Recycling Network has awarded the Baltimore VA Medical ... Outstanding Small Government Program Award for its efforts to promote waste reduction and ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... that Claritas Capital, a Nashville-based private equity firm, has invested $3.35 million in ... for some time, and Claritas Capital offers the smart money, speed to market ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 8, 2017  Less than a month ago, amateur ... 200,000 companies, including hospital networks, in over 150 countries. ... of the largest online extortion attempts ever recorded. With ... it is imperative that providers understand where the risks ... this — and many other very real cyber threats.  ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: